Table 2.

Commercially available multiplex arrays suitable for IVD, which have demonstrated clinical viability and applicability in pre‐clinical validation studies but not demonstrated complete compliance with regulatory parameters (at time of writing) are designated with a ‘–’ in Table 1, but with a ‘+’ in this table

Company	Product	Validation	Reference
Phadia	ImmunoCAP® ISAC	+	9, 10, 11, 12, 13
INDOOR Biotechnologies	IgE–QBA™	+	14, 15, 16
Bio–Rad Laboratories	Bio–Plex® 2200 Autoimmune and Infectious Disease Panels	+	17, 18, 19, 20, 21
Whatman	FAST Quant®	+	17, 22, 23, 45
Myriad RBM	Human MAPs	+	24, 25, 26, 27, 28
Alere	Triage® Cardiac Panel	+	29, 30
Arrayit Corporation	Pathogen Antigen Microarrays	– a
DiaMex	Optiplex Borrelia	–
R&D Systems	Human Cytokine Array Panel A	+	31, 32, 33, 34
RayBiotech	Quantibody®	+	35, 36, 37, 38, 39, 40, 41
Quansys	Q–Plex™ array	+	42, 43, 44, 45
Aushon	Ciraplex®	– a
Meso Scale Discovery	MULTI–ARRAY microplate	+	17, 45, 46, 47, 48, 49, 50
QuantiScientifics, LLC	A2® Multiplex ELISA Human Cytokine Panel	–
eBioscience	FlowCytomix™ Multiplex	+	51, 52, 53, 54, 55
BD Biosciences	CBA Human Th1/Th2/Th17 Kits	+	56, 57, 58
Illumina	VeraCode™	+	59

Commercially available multiplex arrays that have demonstrated neither clinical viability/applicability nor compliance with regulatory body approval parameters but nonetheless may theoretically be applicable for clinical applications are designated with a ‘–’ in this table and Table 1.

^aManufacturer claims validation, although no supportive published data are provided.